Advertisement
Canada markets open in 1 hour 31 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7313
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • Bitcoin CAD

    87,298.50
    -3,681.14 (-4.05%)
     
  • CMC Crypto 200

    1,358.14
    -24.43 (-1.77%)
     
  • GOLD FUTURES

    2,341.90
    +3.50 (+0.15%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,496.50
    -168.00 (-0.95%)
     
  • VOLATILITY

    16.28
    +0.31 (+1.94%)
     
  • FTSE

    8,094.08
    +53.70 (+0.67%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6822
    +0.0003 (+0.04%)
     

India's Dr Reddy's to launch generic COVID-19 Merck pill at about 50 cents

BENGALURU, Jan 4 (Reuters) - Indian drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir, under brand name 'Molflu' and will price it at 35 rupees ($0.4694) per capsule, a company spokesperson said on Tuesday. ($1 = 74.5700 Indian rupees) (Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shinjini Ganguli)